Adaptimmune is a leader in the development of T-cell-based therapies for the treatment of cancer. Adaptimmune has programs in clinical trials as well as an exciting pipeline of new targets. At Adaptimmune, our team is driven by a core goal: That together we can change the way certain cancers are treated, and bring important new T-cell based therapeutics to patients in need.
Based in the heart of Philadelphia, PA, Adaptimmune offers the opportunity to take part in pioneering the development of T cell therapy. The company has an inventive and collaborative culture, where employees are valued and inspired as well as rewarded for their ideas and contributions. The organization of research in Adaptimmune has created an environment where it is possible to make both individual and team contributions towards scientific excellence.
In June 2020, our Company has been awarded “Best Place to Work” by the Philadelphia Business Journal (PBJ), following direct feedback from our colleagues at the Navy Yard.
The award measures various aspects of company culture, the work environment, opportunities for personal and professional growth, trust in leadership, and the ability to embrace new ideas.
Our culture fostered trusting each other, our bravery in handling successes and failures, our ability to collaborate, and our honesty. It is through this that we find solutions to the most challenging issues we face in our fight against cancer.